Showing results (141-150 of 3,692) with videos related to
Sort By:
Pageof 370
International Journal of Clinical Oncology|March 28, 2022
Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in JapanShohei Fujita, Shinichi Sakuramoto, Yutaka Miyawaki, et al.International Journal of Clinical Oncology|February 25, 2022
A prospective observational study of postoperative adjuvant chemotherapy for non-small cell lung cancer in elderly patients (≥ 75 years)Tokujiro Yano, Motoharu Hamatake, Shoji Tokunaga, et al.International Journal of Clinical Oncology|September 16, 2018
Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han populationXu Liu, Xi Huang, Shanshan Zhang, et al.International Journal of Clinical Oncology|September 16, 2018
Burden of cardiovascular disease in Japanese cancer patients and survivors: a single cancer-center study in Niigata CityYuji Okura, Tsugumi Takayama, Kazuyuki Ozaki, et al.International Journal of Clinical Oncology|August 11, 2018
Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinomaAtsunari Kawashima, Motohide Uemura, Taigo Kato, et al.International Journal of Clinical Oncology|August 11, 2018
Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancerHideaki Yahata, Hiroaki Kobayashi, Kenzo Sonoda, et al.International Journal of Clinical Oncology|December 15, 2022
Comparison of survival outcomes between adolescent and young adults and older adults with tongue squamous cell carcinoma: a nationwide database study using the head and neck cancer registry of JapanGo Omura, Seiichi Yoshimoto, Ryoko Rikitake, et al.International Journal of Clinical Oncology|December 19, 2022
Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY studySatoshi Tamada, Masahiro Nozawa, Kojiro Ohba, et al.International Journal of Clinical Oncology|January 3, 2023
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinomaNoboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, et al.International Journal of Clinical Oncology|May 9, 2015
Molecular pathogenesis of multiple myelomaYusuke Furukawa, Jiro KikuchiPageof 370